Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $90,000 | 3 | 87.2% |
| Education | $8,250 | 1 | 8.0% |
| Food and Beverage | $4,977 | 147 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $98,250 | 4 | $0 (2024) |
| Medtronic Vascular, Inc. | $580.05 | 22 | $0 (2020) |
| Abbott Laboratories | $574.73 | 7 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $444.76 | 16 | $0 (2023) |
| ABIOMED | $401.55 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $313.04 | 12 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $302.49 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $292.79 | 19 | $0 (2019) |
| Amgen Inc. | $289.29 | 5 | $0 (2023) |
| Kestra Medical Technology Services, Inc. | $272.91 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,643 | 12 | AngioDynamics, Inc. ($30,000) |
| 2023 | $30,795 | 17 | AngioDynamics, Inc. ($30,000) |
| 2022 | $30,515 | 18 | AngioDynamics, Inc. ($30,000) |
| 2021 | $8,744 | 11 | AngioDynamics, Inc. ($8,250) |
| 2020 | $367.22 | 14 | Janssen Pharmaceuticals, Inc ($127.84) |
| 2019 | $593.34 | 22 | Abbott Laboratories ($156.07) |
| 2018 | $698.58 | 20 | Abbott Laboratories ($373.66) |
| 2017 | $869.79 | 37 | Medtronic Vascular, Inc. ($441.97) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $30,000.00 | General |
| Category: ET | ||||||
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $82.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/01/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $12.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $82.02 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $45.31 | General |
| Category: Cardiology | ||||||
| 06/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $145.58 | General |
| Category: Cardiology | ||||||
| 05/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $143.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $56.98 | General |
| Category: Cardiovascular Device | ||||||
| 12/31/2023 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $30,000.00 | General |
| Category: ET | ||||||
| 11/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $143.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $82.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/26/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiology | ||||||
| 08/15/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $67.19 | General |
| Category: DIABETES | ||||||
| 05/09/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $44.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $78.10 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 04/11/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Stents | ||||||
| 03/14/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,280 | 1,930 | $464,818 | $142,279 |
| 2022 | 13 | 934 | 1,390 | $343,660 | $104,642 |
| 2021 | 10 | 671 | 945 | $228,606 | $71,220 |
| 2020 | 24 | 2,531 | 4,590 | $1.3M | $252,331 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 180 | 435 | $112,036 | $41,701 | 37.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 173 | 190 | $94,620 | $26,653 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 217 | $69,542 | $20,995 | 30.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 28 | 28 | $30,940 | $9,152 | 29.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 120 | 120 | $21,675 | $6,492 | 30.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 38 | 38 | $18,696 | $5,433 | 29.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 28 | 56 | $15,792 | $5,055 | 32.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 23 | 24 | $18,624 | $4,955 | 26.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 23 | 92 | $13,616 | $3,954 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $13,504 | $3,675 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 56 | $12,712 | $3,532 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 53 | $9,565 | $3,391 | 35.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 269 | 390 | $13,650 | $2,470 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $6,149 | $1,612 | 26.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 28 | 28 | $4,928 | $1,358 | 27.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 59 | $2,124 | $668.74 | 31.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 21 | 22 | $1,583 | $435.16 | 27.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 23 | 27 | $945.00 | $317.52 | 33.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 24 | 28 | $3,528 | $291.48 | 8.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 23 | 24 | $589.00 | $138.00 | 23.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 186 | 206 | $102,573 | $32,405 | 31.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 147 | 370 | $95,090 | $30,343 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 104 | $33,586 | $10,060 | 30.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 140 | $25,379 | $7,900 | 31.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 29 | 29 | $22,504 | $6,521 | 29.0% |
About Sameer Chadha
Sameer Chadha is a Cardiovascular Disease healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2010. The National Provider Identifier (NPI) number assigned to this provider is 1164736211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sameer Chadha has received a total of $103,227 in payments from pharmaceutical and medical device companies, with $30,643 received in 2024. These payments were reported across 151 transactions from 31 companies. The most common payment nature is "Long term medical supply or device loan" ($90,000).
As a Medicare-enrolled provider, Chadha has provided services to 5,416 Medicare beneficiaries, totaling 8,855 services with total Medicare billing of $570,472. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Orange City, FL
- Active Since 07/31/2010
- Last Updated 07/21/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164736211
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $98,250
- XARELTO (Drug) $444.76
- Impella (Device) $401.55
- Quadra Assura CRT Defibrillator (Device) $361.44
- BRILINTA (Drug) $313.04
- Resolute (Device) $303.00
- LifeVest (Device) $302.49
- Repatha (Biological) $289.29
- TRELEGY ELLIPTA (Drug) $276.43
- Assure WCD (Device) $272.91
- RESOLUTE ONYX (Device) $229.56
- Ensite Cardiac Mapping System (Device) $182.30
- Micra (Device) $147.86
- AQUADEX SMARTFLOW CONSOLE (Device) $142.87
- Barostim Neo System (Device) $129.00
- VERQUVO (Drug) $126.09
- JARDIANCE (Drug) $120.00
- Reveal LINQ (Device) $105.34
- UPTRAVI (Drug) $97.87
- Hillrom - Carnation Ambulatory Monitor (Device) $78.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orange City
Ratan Ahuja, Md Facc, MD FACC
Cardiovascular Disease — Payments: $31,845
Janak Bhavsar, Md, MD
Cardiovascular Disease — Payments: $17,641
Dr. Rajendra Hippalgaonkar, M.d, M.D
Cardiovascular Disease — Payments: $14,712